COVİD-19 Olgularında BT ile Değerlendirilen Kardiyovasküler ve Metabolik Risk Faktörleri
PDF
Atıf
Paylaş
Talep
P: 39-47
Mart 2022

COVİD-19 Olgularında BT ile Değerlendirilen Kardiyovasküler ve Metabolik Risk Faktörleri

J Turk Soc Intens Care 2022;20(1):39-47
Bilgi mevcut değil.
Bilgi mevcut değil
Alındığı Tarih: 31.12.2021
Kabul Tarihi: 01.04.2022
Yayın Tarihi: 20.09.2022
PDF
Atıf
Paylaş
Talep

ÖZET

Amaç:

Bu çalışmanın amacı koronavirüs hastalığı-2019 (COVİD-19) olgularında risk faktörü olabilecek toraks bilgisayarlı tomografi (BT) tetkiki ile değerlendirilen bazı ölçülebilen parametrelerin dökümente edilmesidir.

Gereç ve Yöntem:

Çalışmada COVİD-19 olguları retrospektif olarak incelendi ve 3 grup oluşturuldu. Grup 1 COVİD-19 pnömonisi nedeni ile normal servislerde veya evde tedavi olan olgular, grup 2 COVİD-19 pnömonisi olan ve yoğun bakım ünitesine (YBÜ) alınan ve yaşayan olgular, grup 3 ise COVİD-19 pnömonisi sonrası eks olan olgulardan oluştu. BT tetkikinde aorta (A) ve pulmoner arter (PA) çapı, PA/A oranı, kardiyotorasik oran (KTO), yağ kas oranı, paraspinal kas densitesi gibi COVİD-19 enfeksiyonu için risk olarak kabul edilen parametreler değerlendirildi.

Bulgular:

Olguların ortanca yaşı 67 yıl idi (Q1: 58-Q3: 75). Olguların %60,6’sı (n=143) erkek hastalardı. Multivariate analizde KTO, erkek ve bayan olgular için YBÜ’ye başvuruda tespit edilen tek risk faktörü idi. Ek olarak COVİD-19’lu erkek olgularda KTÖ ölüm riski ile ilişkili olarak bulunan tek parametre idi. Tüm olgularda PA çapı normalden daha yüksek bulundu. Diğer incelenen parametrelerde gruplar arasında istatistiksel olarak anlamlı bir fark saptanmadı.

Sonuç:

KTO, COVİD-19 olgularının değerlendirilmesinde potansiyel bir risk faktörüdür. PA çapı tüm olgularda yüksek olup akciğer enflamasyonunun bir bulgusu olabilir.

References

1
Karam M, Althuwaikh S, Alazemi M, Abul A, Hayre A, Alsaif A, et al. Chest CT versus RT-PCR for the detection of COVID-19: systematic review and meta-analysis of comparative studies. JRSM Open 2021;12:20542704211011837.
2
Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA 2020;323:2052-9.
3
Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J 2020;55:2000547.
4
Zouk AN, Gulati S, Xing D, Wille KM, Rowe SM, Wells JM. Pulmonary artery enlargement is associated with pulmonary hypertension and decreased survival in severe cystic fibrosis: A cohort study. PLoS One 2020;15:e0229173.
5
Wells JM, Morrison JB, Bhatt SP, Nath H, Dransfield MT. Pulmonary Artery Enlargement Is Associated With Cardiac Injury During Severe Exacerbations of COPD. Chest 2016;149:1197-204.
6
Ogata H, Kumasawa J, Fukuma S, Mizobuchi M, Kinugasa E, Fukagawa M,et al. The cardiothoracic ratio and all-cause and cardiovascular disease mortality in patients undergoing maintenance hemodialysis: results of the MBD-5D study. Clin Exp Nephrol 2017;21:797-806.
7
Okute Y, Shoji T, Hayashi T, Kuwamura Y, Sonoda M, Mori K, et al. Cardiothoracic Ratio as a Predictor of Cardiovascular Events in a Cohort of Hemodialysis Patients. J Atheroscler Thromb 2017;24:412-21.
8
Eslami V, Abrishami A, Zarei E, Khalili N, Baharvand Z, Sanei-Taheri M. The Association of CT-measured Cardiac Indices with Lung Involvement and Clinical Outcome in Patients with COVID-19. Acad Radiol 2021;28:8-17.
9
Gualtieri P, Falcone C, Romano L, Macheda S, Correale P, Arciello P, et al. Body Composition Findings by Computed Tomography in SARS-CoV-2 Patients: Increased Risk of Muscle Wasting in Obesity. Int J Mol Sci 2020;21:4670.
10
Yang Y, Ding L, Zou X, Shen Y, Hu D, Hu X, et al. Visceral Adiposity and High Intramuscular Fat Deposition Independently Predict Critical Illness in Patients with SARS-CoV-2. Obesity (Silver Spring) 2020;28:2040-8.
11
Chandarana H, Dane B, Mikheev A, Taffel MT, Feng Y, Rusinek H. Visceral adipose tissue in patients with COVID-19: risk stratification for severity. Abdom Radiol (NY) 2021;46:818-25.
12
Miller J, Singer A, Hinrichs C, Contractor S, Doddakashi S. Cardiac Dimensions Derived From Helical Ct: Correlation With Plain Film Radiography. The international journal of radiology 1999;1:1-6.
13
Gollub MJ, Panu N, Delaney H, Sohn M, Zheng J, Moskowitz CS, et al. Shall we report cardiomegaly at routine computed tomography of the chest? J Comput Assist Tomogr 2012;36:67-71.
14
Truong QA, Massaro JM, Rogers IS, Mahabadi AA, Kriegel MF, Fox CS, et al. Reference values for normal pulmonary artery dimensions by noncontrast cardiac computed tomography: the Framingham Heart Study. Circ Cardiovasc Imaging 2012;5:147-54.
15
Spagnolo P, Cozzi A, Foà RA, Spinazzola A, Monfardini L, Bnà C, et al. CT-derived pulmonary vascular metrics and clinical outcome in COVID-19 patients. Quant Imaging Med Surg 2020;10:1325-33.
16
Kottlors J, Zopfs D, Fervers P, Bremm J, Abdullayev N, Maintz D, et al. Body composition on low dose chest CT is a significant predictor of poor clinical outcome in COVID-19 disease - A multicenter feasibility study. Eur J Radiol 2020;132:109274.
17
Schiaffino S, Albano D, Cozzi A, Messina C, Arioli R, Bnà C, et al. CT-derived Chest Muscle Metrics for Outcome Prediction in Patients with COVID-19. Radiology 2021;300:E328-36.
18
Ufuk F, Demirci M, Sagtas E, Akbudak IH, Ugurlu E, Sari T. The prognostic value of pneumonia severity score and pectoralis muscle Area on chest CT in adult COVID-19 patients. Eur J Radiol 2020;131:109271.
19
Giraudo C, Librizzi G, Fichera G, Motta R, Balestro E, Calabrese F, et al. Reduced muscle mass as predictor of intensive care unit hospitalization in COVID-19 patients. PLoS One 2021;16:e0253433.
20
Besutti G, Pellegrini M, Ottone M, Cantini M, Milic J, Bonelli E, et al. The impact of chest CT body composition parameters on clinical outcomes in COVID-19 patients. PLoS One 2021;16:e0251768.
21
Kalligeros M, Shehadeh F, Mylona EK, Benitez G, Beckwith CG, Chan PA, et al. Association of Obesity with Disease Severity Among Patients with Coronavirus Disease 2019. Obesity (Silver Spring) 2020;28:1200-4.
22
Ellulu MS, Patimah I, Khaza’ai H, Rahmat A, Abed Y. Obesity and inflammation: the linking mechanism and the complications. Arch Med Sci 2017;13:851-63.
2024 ©️ Galenos Publishing House